0000945621-05-000017.txt : 20120725
0000945621-05-000017.hdr.sgml : 20120725
20050208152444
ACCESSION NUMBER: 0000945621-05-000017
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050208
DATE AS OF CHANGE: 20050208
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSITE INC
CENTRAL INDEX KEY: 0000834306
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 330288606
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-50351
FILM NUMBER: 05583856
BUSINESS ADDRESS:
STREET 1: 11030 ROSELLE ST
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 6194554808
MAIL ADDRESS:
STREET 1: 11030 ROSELLE ST
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: BIOSITE DIAGNOSTICS INC
DATE OF NAME CHANGE: 19960710
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: BLUEWATER INVESTMENT MANAGEMENT INC
CENTRAL INDEX KEY: 0001072554
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: 150 RING STREET WEST
STREET 2: SUITE 1502, BOX 63
CITY: TORONTO
STATE: A6
ZIP: 00000
BUSINESS PHONE: 4165995300
SC 13G
1
biosite.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __)
Biosite Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
90945106
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2004
--------------------------------------------------------------------------------
(Date of Event which Required Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[_] Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13G
1 NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Bluewater Investment Management Inc.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) [X]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Toronto, Ontario, Canada
5 SOLE VOTING POWER
1,055,711
NUMBER OF SHARES
BENEFICIALLY OWNED BY
EACH REPORTING PERSON
WITH
6 SHARED VOTING POWER
Nil
7 SOLE DISPOSITIVE POWER
1,055,711
8 SHARED DISPOSITIVE POWER
Nil
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,055,711
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|_|
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.52%
12 TYPE OF REPORTING PERSON
CO
Item 1. (a). Name of Issuer: Biosite Inc.
(b). Address of Issuer's Principal Executive Offices:
11030 Roselle Street
San Diego, California
U.S.A.
92121
Item 2. (a). Name of Person Filing:
Bluewater Investment Management Inc.
(b). Address of Principal Business Office or, if none, Residence:
Suite 1502, Box 63
150 King Street West
Toronto, Ontario
Canada
M5H 1J9
(c). Citizenship or Place of Organization:
Organized in Toronto, Ontario, Canada
(d). Title of Class of Securities: Common Stock
(e). CUSIP Number: 90945106
Item 3. If this statement is filed pursuant to sections 240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:
(a)[ ] Broker or dealer registered under section 15 of the Act
(15 U.S.C. 78o);
(b)[ ] Bank as defined in section 3(a)(6) of the Act (15
U.S.C. 78c);
(c)[ ] Insurance company as defined in section 3(a)(19) of the
Act (15 U.S.C. 78c.);
(d)[ ] Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)[x] An investment adviser in accordance with section
240.13d-1(b)(1)(ii)(E);
(f)[ ] An employee benefit plan or endowment fund in
accordance with section 240.13d-1(b)(1)(ii) (F);
(g)[ ] A parent holding company or control person in
accordance with section 240.13d-1(b)(1)(ii)(G);
(h)[ ] A savings associations as defined in section 3(b) of
the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)[ ] A church plan that is excluded from the definition of
an investment company under section 3(c)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)[ ] Group, in accordance with section 240.13d-1(b)(1)
(ii)(J).
Item 4. Ownership.
(a). Amount beneficially owned:
1,055,711
(b). Percent of class:
6.52%
(c). Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 1,055,711
(ii) Shared power to vote or to direct the vote: Nil
(iii)Sole power to dispose or to direct the disposition of: 1,055,711
(iv) Shared power to dispose or to direct the disposition of: Nil
Item 5. Ownership of Five Percent or Less of a Class: [ ]
N/A
Item 6. Ownership of More Than Five Percent on Behalf of Another
Person:
N/A
Item 7. Identification and Classification of Subsidiaries which
Acquired the Security Being Reported on by the Parent
Holding Company:
N/A
Item 8. Identification and Classification of Members of the Group:
N/A
Item 9. Notice of Dissolution of Group:
N/A
Item 10. Certification:
(a) The following certification shall be included if the statement is
filed pursuant to 240.13d-1(b):
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired and
are held in the ordinary course of business and were not
acquired and are not held for the purpose of or with the
effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
(b) The following certification shall be included if the statement is
filed pursuant to 240.13d-1(c):
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired and
are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and
were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 7, 2005
Signature: /s/ Dina DeGeer
-----------------------------------
Name/Title: Dina DeGeer